Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Primary familial brain calcification (PFBC) is a rare cerebral microvascular calcifying disorder with a wide spectrum of motor, cognitive, and neuropsychiatric symptoms. It is typically inherited as an autosomal-dominant trait with four causative genes identified so far: SLC20A2, PDGFRB, PDGFB, and XPR1. Our study aimed at screening the coding regions of these genes in a series of 177 unrelated probands that fulfilled the diagnostic criteria for primary brain calcification regardless of their family history. Sequence variants were classified as pathogenic, likely pathogenic, or of uncertain significance (VUS), based on the ACMG-AMP recommendations. We identified 45 probands (25.4%) carrying either pathogenic or likely pathogenic variants (n = 34, 19.2%) or VUS (n = 11, 6.2%). SLC20A2 provided the highest contribution (16.9%), followed by XPR1 and PDGFB (3.4% each), and PDGFRB (1.7%). A total of 81.5% of carriers were symptomatic and the most recurrent symptoms were parkinsonism, cognitive impairment, and psychiatric disturbances (52.3%, 40.9%, and 38.6% of symptomatic individuals, respectively), with a wide range of age at onset (from childhood to 81 years). While the pathogenic and likely pathogenic variants identified in this study can be used for genetic counseling, the VUS will require additional evidence, such as recurrence in unrelated patients, in order to be classified as pathogenic

Oleocanthalic acid from extra-virgin olive oil: Analysis, preparative isolation and radical scavenging activity

Oleocanthal is a nutraceutical compound present in extra-virgin olive oil (EVOO), endowed with several health properties, such as anti-inflammatory, neuroprotective and anticancer effects. During the EVOO storage, oleocanthal can undergo oxidative processes that lead to the formation of oleocanthalic acid. The aim of this work was to develop a reproducible and efficient method for isolation and purification of oleocanthalic acid with the purpose to obtain enough amount of this compound for further pharmacological investigations. We heated an EVOO rich in oleocanthal at 80 °C for 14 days to favour the oxidation of oleocanthal. Subsequently, the oleocanthalic acid was extracted from this EVOO and purified through a combination of direct phase and reverse phase chromatography. The pure oleocanthalic acid was used to develop a HPLC method for qualitative and quantitative analysis of oleocanthalic acid content in EVOO. A preliminary assessment of the radical scavenging potential against oxygen species (superoxide anion radical (O2[rad]−), hypochlorous acid (HOCl) and peroxyl radical (ROO[rad])) was also screened. The results showed the quenching efficiency of oleocanthalic acid for HOCl followed by O2[rad]−